Category: biotech

.Vir Medical’s second-quarter earnings document had not been short of significant updates. The firm welcomed a trio of clinical-stage T-cell engagers (TCEs) coming from Sanofi

.Vertex’s attempt to treat an unusual hereditary ailment has attacked one more problem. The biotech threw two additional drug prospects onto the throw away pile

.Ventyx Biosciences’ Crohn’s disease medication carried out not help clients obtain remission in a stage 2 test, sending out the California biotech’s portions down over

.Vaxcyte introduced what experts called “stunning” period 1/2 records for its 31-valent pneumococcal vaccination applicant that, if reproduced in a big crucial study, might pose

.Vaderis Rehabs’ target to build the initial drug targeted especially at a specific uncommon capillary ailment arrived one action more detailed today with the news

.Immune checkpoint inhibitors are actually the superheroes of cancer treatment. Drugs like Bristol Myers Squibb’s Opdivo and Merck’s Keytruda are actually amongst the best profitable

.Immunology biotech VBI Vaccinations is drifting hazardously close to the defining moment, along with strategies to declare bankruptcy and liquidate its assets.The Cambridge, Mass.-based company

.Upstream Biography possesses swollen its IPO to $255 million as the company signs up with CAMP4 Rehabs today in becoming the current biotechs to detail

.A minority of clients taking Ultragenyx Pharmaceutical’s Wilson health condition gene therapy UX701 have actually come off standard-of-care medicines, leading the biotech to register a

.Adhering to the announcement of a huge layoff round in April and also a significant restructuring initiative unveiled earlier this month, Genentech is sending out